Clinical Trials Sponsored by Autophagy Sciences, Inc.

Total 1393 results

Sight Sciences, Inc.

Unknown

TearCare System to Treat Dry Eye Disease (OLYMPIA)

Dry Eye | Meibomian Gland Dysfunction

United States
Sight Sciences, Inc.

Unknown

Study of the TearCare System in Dry Eye Disease

Dry Eye

United States
Sight Sciences, Inc.

Unknown

Pilot Study of the TearCare System

Dry Eye

United States
MELA Sciences, Inc.

Terminated

Post-Approval Study of MelaFind

Melanoma

United States
MELA Sciences, Inc.

Completed

MelaFind Evaluations for Patients With Multiple Nevi

Clinically Atypical Pigmented Skin Lesion
Dermavant Sciences GmbH

Completed

Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults

Atopic Dermatitis

United States, Canada
Dermavant Sciences GmbH

Completed

Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)

Atopic Dermatitis

United States, Canada
Dermavant Sciences GmbH

Completed

Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis

Plaque Psoriasis

United States
Respivant Sciences GmbH
Respivant Sciences Inc.

Terminated

A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF (SCENIC)

Chronic Cough | IPF | Persistent Cough in IPF

United States, United Kingdom, Netherlands, Australia, Belgium, New Zealand, Turkey, Italy, Germany, Czechia, Canada
Respivant Sciences GmbH
Respivant Sciences Inc.

Completed

Open-label Study of Inhaled RVT-1601 in Preterm Infants

Respiratory Morbidities of Prematurity (RMP)

United States
Dermavant Sciences GmbH

Completed

Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis

Atopic Dermatitis

United States, Canada
Dermavant Sciences GmbH

Completed

A Phase 2 Study of E6005 in Patients With Atopic Dermatitis

Atopic Dermatitis

Japan
Kinevant Sciences GmbH
Roivant Sciences, Inc.

Completed

A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)

COVID-19

United States
Dermavant Sciences GmbH

Completed

Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo

Vitiligo

United States
Dermavant Sciences GmbH

Completed

Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis

Atopic Dermatitis

Canada, United States
Dermavant Sciences GmbH

Unknown

Open-Label Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis

Atopic Dermatitis

United States
Dermavant Sciences GmbH

Completed

A Phase 1/2 Study of E6005 in Pediatric Subjects With Atopic Dermatitis

Atopic Dermatitis

Japan
Dermavant Sciences GmbH

Completed

A Study of E6005 in Japanese Patients With Atopic Dermatitis

Atopic Dermatitis

Japan
ReAlta Life Sciences, Inc.

Not yet recruiting

Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refractory Acute Graft-versus-Host Disease (AURORA)

Steroid Refractory GVHD
Power Life Sciences Inc.

Not yet recruiting

Examining Engagement Trends Among Participants in Peripheral Neuropathy Clinical Research

Peripheral Neuropathy

United States
Power Life Sciences Inc.

Not yet recruiting

Assessing Patient Engagement in Keratoconus Clinical Research

Keratoconus

United States
Power Life Sciences Inc.

Not yet recruiting

Delving Into Participation Trends of Scleroderma Clinical Trials

Scleroderma

United States
Power Life Sciences Inc.

Not yet recruiting

Studying Patterns in Patient Engagement Among Tardive Dyskinesia Patients

Tardive Dyskinesia

United States
Power Life Sciences Inc.

Not yet recruiting

Exploring Clinical Study Experiences of People With Anorexia Nervosa

Anorexia Nervosa

United States
Power Life Sciences Inc.

Not yet recruiting

Revealing Engagement Patterns Among Hepatic Encephalopathy Patients

Hepatic Encephalopathy

United States
Power Life Sciences Inc.

Not yet recruiting

Evaluating the Occurrence of Participation Trends Among Weight Loss Clinical Trials Patients

Weight Loss

United States
Power Life Sciences Inc.

Not yet recruiting

Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients

Recurrent Prostate Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Insights Into Participating in Studies for Bone Cancer

Bone Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients

Recurrent Ovarian Cancer

United States
TransThera Sciences (Nanjing), Inc.

Recruiting

Study of TT-00420 (Tinengotinib) in Subjects With Cholangiocarcinoma Who Failed or Relapsed to Chemotherapy and FGFR Inhibitor

Cholangiocarcinoma Metastatic

China
Power Life Sciences Inc.

Not yet recruiting

Investigating Engagement Patterns and Participation Trends Among Liposarcoma Patients

Liposarcoma

United States
Power Life Sciences Inc.

Not yet recruiting

Understanding Engagement Trends in Chondrosarcoma Clinical Trials

Chondrosarcoma

United States
Power Life Sciences Inc.

Not yet recruiting

Delving Into Participation Patterns in Social Anxiety Studies

Social Anxiety

United States
Power Life Sciences Inc.

Not yet recruiting

Revealing Engagement Patterns Among Endometrial Cancer Patients

Endometrial Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Insights Into Participating in Studies for Uterine Cancer

Uterine Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Delving Into Borderline Personality Disorder Clinical Trial Experiences

Borderline Personality Disorder

United States
Power Life Sciences Inc.

Not yet recruiting

Evaluation of Study Experiences of Neuroendocrine Tumor Patients

Neuroendocrine Tumors

United States
Power Life Sciences Inc.

Not yet recruiting

Navigating the Clinical Research Process for Glioma

Glioma

United States
Power Life Sciences Inc.

Not yet recruiting

Evaluating Factors In Study Experiences of Lymphedema Patients

Lymphedema

United States
Power Life Sciences Inc.

Not yet recruiting

Assessment of Schizophrenia Patients' Clinical Study Experiences

Schizophrenia

United States
TransThera Sciences (Nanjing), Inc.

Recruiting

Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma (FIRST-308)

Cholangiocarcinoma

Korea, Republic of, United States, Taiwan, Spain, France, Belgium, Germany, Italy, Portugal, United Kingdom, Austria, Poland
Power Life Sciences Inc.

Not yet recruiting

Studying Patient Experiences in Osteoporosis Clinical Trials

Osteoporosis

United States
Power Life Sciences Inc.

Not yet recruiting

Discovering Clinical Study Experiences of Patients With Pulmonary Hypertension

Pulmonary Hypertension

United States
Power Life Sciences Inc.

Not yet recruiting

A Detailed Look At What Patients Experience When They Take Part In Hypertension Clinical Trials

Hypertension

United States
Power Life Sciences Inc.

Not yet recruiting

Taking a Look at Patient Experiences In Rectal Cancer Clinical Trials

Rectal Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Determining Clinical Study Experiences of Chronic Lymphocytic Leukemia Patients

Chronic Lymphocytic Leukemia

United States
Power Life Sciences Inc.

Not yet recruiting

Examination of Trends in Colorectal Cancer Patients' Clinical Study Experiences

Colorectal Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Examining Clinical Research Participation for Substance Abuse Disorder Patient

Substance Abuse Disorder

United States
Power Life Sciences Inc.

Not yet recruiting

Examination of Trends in Multiple Myeloma Trial Patient Experiences

Multiple Myeloma
Power Life Sciences Inc.

Not yet recruiting

Navigating the Clinical Trial Process for Hepatocellular Carcinoma

Hepatocellular Carcinoma

Clinical Trials Sponsored by Autophagy Sciences, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations